Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Future Management of Waldenstrom Macroglobulinemia
Following a discussion on the multidisciplinary management of Waldenström Macroglobulinemia, Steven P. Treon, MD, PhD, reflects on the future management of this disease.
BTK Inhibitors in WM: Understanding Safety/Efficacy
Steven P. Treon, MD, PhD, provides insight on balancing safety and efficacy while treating Waldenström macroglobulinemia with BTK inhibitors.
Targeted Approaches in Waldenstrom Macroglobulinemia
Key opinion leader Steven P. Treon, MD, PhD, reviews the advent of targeted therapy for patients with Waldenström macroglobulinemia.
Selecting Therapy Through Multiple Lines in WM
Moving to the second-line setting and beyond, an expert discusses the importance of sequencing and quality of life in managing Waldenström macroglobulinemia.
Waldenstrom Macroglobulinemia: Evolving Frontline Treatment
Given the advent of targeted therapy, Steven P. Treon, MD, PhD, reflects on how the frontline management of Waldenström macroglobulinemia is changing.
A Historic Perspective on Frontline WM Management
An expert provides his perspective on the historic frontline management of patients with Waldenström macroglobulinemia.
Waldenstrom Macroglobulinemia: When to Initiate Therapy
As Waldenström macroglobulinemia does not always merit immediate treatment, Steven P. Treon, MD, PhD, discusses watch-and-wait methodology.
Factors Impacting a Diagnosis and Prognosis of WM
A detailed overview of specific tests and factors that impact the diagnosis and prognosis of Waldenström macroglobulinemia is provided.
Waldenstrom Macroglobulinemia: Establishing a Diagnosis
In light of challenges present in diagnosing Waldenström macroglobulinemia, Steven P. Treon, MD, PhD, discusses what tests and factors are useful in this setting.
Risk Factors in Developing Waldenstrom Macroglobulinemia
A key opinion leader shares which factors indicate risk for developing Waldenström macroglobulinemia.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: